glp-1 psychiatry Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Transformation 2.0: The GLP-1 RAs

PMID: 39536238 Aroda VR, Rosenstock J, Terauchi Y, et al

If you have been researching GLP-1 medications for weight loss, the sticker shock is likely the first thing that stopped you in your tracks

Solid line indicates reduction in amyloid burden associated with higher endogenous GLP-1 concentration (pg/ml)

In addition, since the first evidence of a beneficial effect of GLP-1RAs in BAD treatment was not available until 2019, we notice that the prescriptions of GLP-1RAs up until this year were made for other indications than BAD in contrast to bile acid sequestrants

Eur J Pharmacol (2015) 746:30816.10.1016/j.ejphar.2014.10.046 140 GotohKFukagawaKFukagawaTNoguchiHKakumaTSakataTet alHypothalamic neuronal histamine mediates the thyrotropin-releasing hormone-induced suppression of food intake

Physical activity increases blood flow to muscles and surrounding tissue, which can accelerate medication absorption beyond the intended rate